Proof of Concept Study of Re-treatment in BRVO With Ranibizumab Guided by OCT

Summary

The aim of the trial is to evaluate the efficacy and safety of intravitreal injections of ranibizumab for the treatment of macular edema due to BRVO if the re-treatment regimen is guided by morphological macular changes detected by OCT compared to re-treatment according to SmPC defined re-treatment criteria (in case of increase of CRT and concomitant decrease of BCVA).

Timeline

Start

2013-10

Primary completion

2016-06-17

Completion

2016-12-20

Drugs

Indications